- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 07.07. | Cuprina Holdings LTD - F-1, Registration statement for certain foreign private issuers | 2 | SEC Filings | ||
| 24.06. | Morning Market Movers: Cuprina Holdings, CEA Industries, Absci, The Wendy's Company See Big Swings | 934 | AFX News | MEMPHIS (dpa-AFX) - At 7:10 a.m. ET on Wednesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| 16.06. | Cuprina Holdings Falls 22% After 112% Rally - Here's Why CUPR Stock Is Trending | 4 | Benzinga.com | ||
| 15.06. | Cuprina erhält FDA-Zulassung für Produkt zur Madentherapie | 8 | Investing.com Deutsch | ||
| CUPRINA HOLDINGS Aktie jetzt für 0€ handeln | |||||
| 15.06. | Cuprina receives FDA clearance for maggot wound therapy product | 1 | Investing.com | ||
| 15.06. | Cuprina Holdings (Cayman) LTD: Cuprina Receives U.S. FDA 510(k) Clearance for MEDIFLY Maggots - the First U.S. Clearance for a Lucilia cuprina Maggot Debridement Product | 386 | GlobeNewswire (Europe) | SINGAPORE, June 15, 2026 (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) ("CUPR" or "the Company"), a biomedical company developing and marketing products for the chronic wounds... ► Artikel lesen | |
| 12.06. | Cuprina Holdings (Cayman) Limited Regains Compliance with Nasdaq Listing Requirements | 478 | GlobeNewswire (Europe) | SINGAPORE, June 12, 2026 (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) ("Cuprina" or "the Company"), a biomedical company developing and marketing products for the chronic wounds... ► Artikel lesen | |
| 12.06. | Cuprina Holdings LTD - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 29.05. | Cuprina requests Nasdaq hearing after delisting notice | 2 | Investing.com | ||
| 29.05. | Cuprina Holdings (Cayman) LTD: Cuprina Holdings Announces Completion of Reverse Stock Split and Requests a Hearing before the Nasdaq Hearings Panel to Maintain Listing | 237 | GlobeNewswire (Europe) | SINGAPORE, May 29, 2026 (GLOBE NEWSWIRE) -- Cuprina Holdings Cayman Limited Nasdaq: CUPR) ("Cuprina" or "the Company"), a biomedical company developing and marketing products for the chronic wounds... ► Artikel lesen | |
| 22.05. | Cuprina to implement 1-for-8 share consolidation to address Nasdaq compliance | 1 | Seeking Alpha | ||
| 22.05. | Cuprina plant Aktienzusammenlegung im Verhältnis 1:8 zur Sicherung der NASDAQ-Notierung | 5 | Investing.com Deutsch | ||
| 22.05. | Cuprina plans 1-for-8 reverse stock split to meet Nasdaq rules | 1 | Investing.com | ||
| 22.05. | Cuprina Holdings (Cayman) LTD: Cuprina Holdings announces 1-for-8 Share Consolidation | 428 | GlobeNewswire (Europe) | SINGAPORE, May 22, 2026 (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) ("Cuprina" or "the Company"), a biomedical company developing and marketing products for the chronic wounds... ► Artikel lesen | |
| 14.05. | Cuprina Holdings LTD - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 27.04. | Cuprina Holdings LTD - 20-F, Annual and transition report of foreign private issuers | - | SEC Filings | ||
| 21.04. | Cuprina Holdings LTD - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 11.03. | Cuprina Holdings (Cayman) LTD: Cuprina Holdings Announces Key Regulatory Milestone in Saudi Arabia and Strengthens Global Scientific Advisory Board | 810 | GlobeNewswire (Europe) | SINGAPORE, March 11, 2026 (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) ("Cuprina" or "the Company"), a biomedical company developing and marketing products for the chronic... ► Artikel lesen | |
| 11.03. | Cuprina Holdings LTD - 6-K, Report of foreign issuer | 3 | SEC Filings | ||
| 09.12.25 | Cuprina Holdings (Cayman) Limited Announces Financial Results for the Six Months Ended June 30, 2025, and Strategic Initiatives for 2026 Growth | 429 | GlobeNewswire (Europe) | SINGAPORE, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) ("Cuprina" or "the Company"), a biomedical company developing and marketing products for the chronic wounds... ► Artikel lesen |
1 2 Weiter >>
21 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| CO-DIAGNOSTICS | 1,230 | 0,00 % | Co-Diagnostics Reports Second Quarter 2026 Financial Results | Advancing Commercialization Through FDA Submission, Global Clinical Progress and Manufacturing Expansion
Strengthening Integrated Co-Dx PCR Platform Through Scientific... ► Artikel lesen | |
| CYTOSORBENTS | 0,274 | 0,00 % | Cytosorbents Corp: CytoSorbents Reports Second Quarter 2026 Financial Results, Recent Business Highlights, and Regulatory Update | Highlighting Four Independent Drivers of Shareholder Value
PRINCETON, N.J., Aug. 6, 2026 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the... ► Artikel lesen | |
| CLOVER HEALTH INVESTMENTS | 3,580 | +1,13 % | CLOVER HEALTH INVESTMENTS, CORP. /DE - 8-K, Current Report | ||
| FULGENT GENETICS | 17,000 | -0,58 % | Fulgent expects $330M-$340M 2026 revenue as billing transition lowers collection rates | ||
| EMBECTA | 4,178 | -2,93 % | Embecta Corp.: embecta appoints Nimish Muzumdar as SVP and President, North America | PARSIPPANY, N.J., June 16, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical... ► Artikel lesen | |
| CHECK-CAP | 6,750 | -3,57 % | Check-Cap Ltd - 6-K, Report of foreign issuer | ||
| ELECTROCORE | 8,500 | -3,41 % | electroCore, Inc.: electroCore's Truvaga Named Best Luxury Biohacking & Longevity Brand in the USA by Luxury Lifestyle Awards | ||
| MEDLINE | 31,000 | +3,33 % | Medline Inc.: Medline Reports Second Quarter and First Six Months 2026 Results | Second quarter net sales of $7.7 billion, an increase of 11.6%Second quarter net income of $139 million, a decrease of 58.3%Second quarter Adjusted EBITDA1 of $1.1 billion, an increase of 13.4%First... ► Artikel lesen | |
| CATHETER PRECISION | 0,206 | -0,68 % | Catheter Precision, Inc.: Flyte Surpasses 10,000 Consumer Accounts as WebApp Growth Accelerates | ||
| CLEARPOINT NEURO | 16,590 | -2,18 % | ClearPoint Neuro, Inc.: ClearPoint Neuro Reports Second Quarter 2026 Results | Positive BioPharma Partner Regulatory Progress and Early Success in Focused Ultrasound Technology Platform Expansion SOLANA BEACH, CA / ACCESS Newswire / August 3, 2026 / ClearPoint Neuro, Inc. (Nasdaq:CLPT)... ► Artikel lesen | |
| ENVUE MEDICAL | 0,380 | -1,27 % | ENvue Medical: Revenue Jumps 275% As Hospital Adoption Offsets PainShield Production Shutdown | ||
| OMADA HEALTH | 20,800 | +0,97 % | Omada Health, Inc.: Omada Health Joins Lilly Employer Connect, Expanding Its Access Pathways for GLP-1 Care as Patients Seek More Lifestyle Support | SAN FRANCISCO, May 07, 2026 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA) announced it will serve as an independent program administrator in Eli Lilly and Company's Employer Connect program. Omada... ► Artikel lesen | |
| ENDRA LIFE SCIENCES | 4,710 | 0,00 % | ENDRA Life Sciences Swings To Q2 Profit On Digital Asset Gains Ahead Of Noble Africa Merger | ||
| FEMASYS | 2,880 | +1,05 % | Femasys Inc.: Femasys Announces FDA Approval of Modular PMA Submission Approach for FemBloc | ATLANTA, Aug. 19, 2026 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator developing transformative fertility and non-surgical permanent birth control solutions designed... ► Artikel lesen | |
| FIREFLY NEUROSCIENCE | 1,020 | -0,97 % | Firefly Neuroscience, Inc.: Firefly Neuroscience (NASDAQ: AIFF) Reports 291% Increase in TMS Center Customer Brain Scan Volumes | KENMORE, N.Y., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. ("Firefly" or the "Company") (NASDAQ: AIFF), an Artificial Intelligence ("AI") company advancing precision neuroscience... ► Artikel lesen |
Das Unternehmen CUPRINA HOLDINGS CAYMAN LIMITED kann der Branche Gesundheitswesen zugeordnet werden. Mit einer aktuellen Kursveränderung von -0,070 (-2,40 %) liegt der Kurs bei 2,850 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CUPRINA HOLDINGS CAYMAN LIMITED finden Sie auf Wallstreet Online.